Project Details
Description
Dr. Shira Dinner (4.8 calendar months) {budget/project period is six months} - will serve as Executive Officer for the Alliance for Clinical Trials in Oncology (Alliance) and the Alliance Foundation Trials, LLC (AFT). She will oversee the development of protocols for Leukemia, Lymphoma, Myeloma and Transplant; perform operational review on concepts; collaborate with and assist protocol coordinators with protocol development relating to eligibility, testing, observation, schedule, treatment plan and dose modifications. She will review protocols, consents and correspondence about protocols prior to NCI submissions; participate in relevant committee, governmental agency, pharmaceutical partner and research-partner teleconferences. Dr. Dinner will work with protocol budgets, including determining costs for standard of care, reasonable reimbursement for research-related procedures and drafting budgets for requests from industry or Foundation partners, as well as BIQSFP. She will assist with adverse event review for protocols from assigned committees. Dr. Dinner will manage and triage eligibility/treatment/dose modification questions on protocols in the absence of study chair.
Status | Finished |
---|---|
Effective start/end date | 9/1/17 → 2/28/19 |
Funding
- Brigham and Women’s Hospital (110408 // 5U10CA180821-04)
- National Cancer Institute (110408 // 5U10CA180821-04)
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.